Evaluation of important prognostic clinical and pathological factors in gastric cancer

Anticancer Research

Volumn 32, Issue 5, 2012, Pages 1839-1842

  Cammerer, Gregor ^a   Formentini, Andrea ^a   Karletshofer, Markus ^a   Henne Bruns, Doris ^a   Kornmann, Marko ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Gastric cancer; Prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PARTIAL GASTRECTOMY; PRIORITY JOURNAL; STOMACH CANCER; TOTAL STOMACH RESECTION; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84861493961     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Alberts SR, Cervantes A and van de Velde CJ: Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 14(Suppl 2): 31-36, 2003.
2. Cheung TK, Xia HH and Wong BC: Helicobacter pylori eradication for gastric cancer prevention. J Gastroenterol 42(Suppl 17): 10-15, 2007. (Pubitemid 46140357)
3. Roder DM: The epidemiology of gastric cancer. Gastric Cancer 5(Suppl 1): 5-11, 2002.
4. Kaposztas Z, Kalmar K, Cseke L, Illenyi L, Kelemen D and Horvath OP: Prognostic factors in the surgical treatment of gastric cancer - 10 years' experience. Magy Seb 60: 71-78, 2007.
5. Smith BR and Stabile BE: Aggressive D2 lymphadenectomy is required for accurate pathologic staging of gastric adenocarcinoma. Am Surg 72: 849-852, 2006. (Pubitemid 351837616)
6. Novotny AR, Schuhmacher C, Busch R, Kattan MW, Brennan MF and Siewert JR: Predicting Individual Survival After Gastric Cancer Resection. Ann Surg 243: 74-81, 2006.
7. Liu C, Lu P, Lu Y, Xu H, Wang S and Chen J: Clinical implications of metastatic lymph node ratio in gastric cancer. BMC Cancer 7: 200, 2007.
8. McCulloch P, Niita ME, Kazi H and Gama-Rodrigues JJ: Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg 92: 5-13, 2005. (Pubitemid 40144187)
9. Siewert JR, Böttcher K, Stein HJ and Roder JD: Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228: 449-461, 1998. (Pubitemid 30194389)
10. Ahn JR, Jung M, Kim C, Hong MH, Chon HJ, Kim HR, Jeung HC, Hyung WJ, Lee SS, Chung HC, Noh SH and Rha SY: Prognosis of pN3 Stage Gastric Cancer. Cancer Res Treat 41: 73-79, 2009.
11. Cidón EU: Gastric cancer and the search for a good prognostic classification: a challenge. Clin Exp Gastroenterol 3: 113-116, 2010.
12. Huang CM, Lin JX, Zheng CH, Li P, Xie JW, Lin BJ and Wang JB: Prognostic impact of metastatic lymph node ratio on gastric cancer after curative distal gastrectomy. World J Gastroenterol 16: 2055-2060, 2010.
13. Wang W, Li YF, Sun XW, Chen YB, Li W, Xu DZ, Guan XX, Huang CY, Zhan YQ and Zhou ZW: Prognosis of 980 patients with gastric cancer after surgical resection. Mayo Clin Proc 85: 1080-1089, 2010.
14. Jang YJ, Park MS, Park SS, Kim JH, An H, Park SH, Kim SJ, Kim CS and Mok YJ: Surgeon subspecialty as a factor in improving long-term outcomes for gastric cancer: Twenty years of experience in Korea. Arch Surg 145: 1091-1096, 2010.
15. Lee SB, Kim JH, Kim DH, Jeon TY, Kim DH, Kim GH and Park do Y: Clinicopathological characteristics and prognosis of remnant gastric cancer. J Gastric Cancer 10: 219-225, 2010
16. Tapia O, Villaseca M, Bellolio E, Araya JC and Roa JC: Prognostic factors for gastric cancer without lymph node involvement. Rev Med Chil 139: 992-997, 2011